Clinical Trial: Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Brief Summary:

Primary objectives:

  1. To assess the short-term efficacy of risperidone augmentation for treatment-resistant aggression in children with ADHD.
  2. To assess the short-term safety and tolerability of risperidone augmentation in the same group of subjects.